Healthcare investment firm Patient Square Capital aims to raise more than $6 billion for its second fund focused on healthcare services, according to PitchBook. Four things to know:1. Patient Square Capital is a middle-market investor that raised $3.9 billion for its first fund last year. The funding round was led by Jim Momtazee, managing partner of Patient Square.

据PitchBook报道，医疗投资公司Patient Square Capital计划为其第二只专注于医疗服务的基金筹集60多亿美元。要知道四件事：1。Patient Square Capital是一家中等市场投资者，去年为其第一只基金筹集了39亿美元。这轮融资由Patient Square的管理合伙人吉姆·蒙塔泽（JimMomtazee）牵头。

He spent two decades at private equity firm KKR before joining Patient Square.2. The new fund is focused on deals for drug development, medical adhesives, healthcare providers and tech-enabled healthcare services, according to the report. Patient Square expects to close the fundraising round before the year's end.3.

在加入Patient Square之前，他在私人股本公司KKR工作了20年。据报道，新基金专注于药物开发、医用粘合剂、医疗保健提供者和技术支持的医疗保健服务。Patient Square预计在年底前结束募捐。

Patient Square, Elliott Investment Management and Veritas Capital acquired Syneos Health, a biopharmaceutical company, for $7.1 billion last year.4. Patient Square's portfolio companies include Access TeleCare, Apollo Therapeutics, Hanger, Kriya, resolve biosciences and Elevage Medical Technologies..

Patient Square、Elliott Investment Management和Veritas Capital去年以71亿美元收购了生物制药公司Syneos Health。Patient Square的投资组合公司包括Access TeleCare、Apollo Therapeutics、Hanger、Kriya、resolve biosciences和Elevate Medical Technologies。。